Question 1

What is the catalog number for Anti-CD40 Antibody (9Q945)?

Accepted Answer

The catalog number for Anti-CD40 Antibody (9Q945) is TMAY-03760.

Question 2

What sizes are available for Anti-CD40 Antibody (9Q945)?

Accepted Answer

Anti-CD40 Antibody (9Q945) is available in the following size(s): 100 µL.

Question 3

Is Anti-CD40 Antibody (9Q945) in stock?

Accepted Answer

Anti-CD40 Antibody (9Q945) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures Anti-CD40 Antibody (9Q945)?

Accepted Answer

Anti-CD40 Antibody (9Q945) is manufactured by Molfinity.

Question 5

What is the estimated delivery time for Anti-CD40 Antibody (9Q945)?

Accepted Answer

Estimated delivery time for Anti-CD40 Antibody (9Q945) is approximately 10 business day(s), depending on your location.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 8

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Anti-CD40 Antibody (9Q945)

Product Specifications

Bioactivity

Shipping Conditions

Storage Temperature

Frequently Asked Questions

Explore Other Products

2-(2-Chloroethoxy)ethylphosphonic Acid

Tissue FFPE Sections, Lung

TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2151), 0.2mg/mL

AF/LE Purified Anti-Human CD16 Antibody[3G8]

AF/LE Purified Anti-Human CD16 Antibody[3G8]

AF/LE Purified Anti-Human CD16 Antibody[3G8]